483 Catalent Pharma Solutions Dec 2018

483 Catalent Pharma Solutions Dec 2018

Andrew Barrowcliff FDA, Wayne Mcgrath FDA, Chiaochun Wang FDA$119.00 - Available Now

FDA investigators audited the Catalent Pharma Solutions - Winchester, KY, United States facility and issued inspectional observations (via FDA 483) on 21 Dec 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 21 Dec 2018
  • Location: Winchester, United States
  • FEI: 1000122400
Add To Cart